Centre de médecine virtuelle

Un centre pionnier dans l’intégration des nouvelles technologies de réalité virtuelle et de l’Internet des objets à la recherche clinique et aux pratiques médicales.

Titre
Secrétariat
Adresse

Laura Mifano
Switzerland

Titre
Coordinatrice
Adresse

Giannina Rita Iannotti, PhD-PD
Switzerland

Adresse

Centre de médecine virtuelle
Olivier Kannape
Switzerland

Centre for virtual medicine

Mission of the Centre for Virtual Medicine

The Centre for Virtual Medicine (CMV) focuses on the integration of virtual reality and related new technologies in clinical research and patient care.

It provides the expertise and technological infrastructure necessary to transfer innovation and translate basic research to the clinical environment.

The CMV is the result of a collaboration between the Department of Clinical Neurosciences, the Department of Medicine and the Department of Diagnostics at the HUG, the Medical Faculty at Unige, in close collaboration with the EPFL. It lies at the interface between engineering, medicine and human behavioural research, and focuses on the application of technological advances to clinical research, both at the bedside of patients in hospital and in their homes.

The Centre's objectives

The CMV is a pioneer in the use of the latest virtual reality technologies (virtual reality, immersive virtual reality, augmented reality or mixed reality) and the Internet of Things (IoT, smart healthcare, wearables, remote monitoring) for clinical research and new medical practice for research, diagnostics, anaesthesia and therapy, and for patient well-being.

The CMV is open to the development of applications in all medical fields: surgery, internal medicine, neurology and psychiatry, intensive care, anaesthesiology, orthopaedics, rehabilitation medicine, geriatrics and palliative care.

The CMV is an important link to Campus Biotech within the HUG. It brings the specific skills and solutions developed at Campus Biotech to the patients’ bedside. It facilitates clinical research and the development of new technologies with and for HUG patients, involving research, diagnostics and new therapies. The CMV stimulates collaboration between engineers, virtual reality specialists, neuroscientists, clinical researchers and physicians in three key areas:

  • Clinical research
  • Patient care
  • Medical training

The Centre's research activities

The CMV also provides direct support to research and application projects. It is an active centre for fundamental and translational patient research.  It is composed of engineers and clinical assistants as well as junior and senior research assistants, financed by research grants and joint collaborations between the HUG, the Geneva Campus Biotech Foundation, the EPFL and the HES schools.
 

Partners

The CMV works hand in hand with academic partners such as the EPFL and the University of Geneva, as well as with specialist companies such asMindMaze SA or OramaVR.

Oliver Kannape, PhD, Director of the Centre for Virtual Medicine

A cognitive scientist by training, Oliver Kannape is interested in translating neuroscientific findings into clinical applications using virtual reality and related technologies.

After completing his PhD on cognitive and sensorimotor contributions to human locomotion, for which he was awarded the Pfizer Research Prize, Oliver Kannape joined the Massachusetts Institute of Technology (MIT), where he developed a neural interface for the voluntary control of a motorized lower limb prosthesis sponsored by the Swiss National Science Foundation. Prior to joining the HUG, he was an assistant professor in cognitive neuroscience at the UCLan, before spending the last four years as scientific coordinator at  MindMaze SA and EPFL, where he developed augmented reality and virtual reality applications for symptom relief in indications such as chronic pain and dyspnoea, as well as for the assessment and treatment of substance use disorders – experience he now brings to the CMV.

Last update : 09/01/2024

News & Events

13.05.2024

VMC VR Simulations featured on RTS 19h30

12 décembre 2023

Release of the Swiss Brain Health Plan 2023-2033

Vendredi 24 novembre 2023

Séminaire GCIR : "Sex and gender aspects of inflammatory cardiovascular disease"